Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
批准号:
8460123
负责人:
Pinghui Feng
金额:
$31.03万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-10 至 2016-04-30
关键词:
ApoptosisBiochemicalBiologicalBiological AssayCell DeathCellsComplexDisease ProgressionDominant-Negative MutationEndoplasmic Reticulum Degradation PathwayEukaryotic CellEventG-Protein-Coupled ReceptorsGeneticHerpesviridaeHerpesviridae InfectionsHumanHuman Herpesvirus 8Immunologic Deficiency SyndromesInfectionInflammationKaposi SarcomaLesionLinkLyticLytic PhaseMalignant NeoplasmsMammalian CellMediatingMembrane ProteinsMissionMolecularMulticentric Angiofollicular Lymphoid HyperplasiaPapillomaPathogenesisPathway interactionsPatientsPost-Translational RegulationProteinsProteolysisRegulationRetinalRhodopsinRoleSignal TransductionSystemTumorigenicityUbiquitinationViralViral ProteinsVirusabstractinggammaherpesvirusgrowth promoting activitylytic replicationmouse modelmulticatalytic endopeptidase complexoverexpressionp97 ATPasepost-doctoral trainingprimary effusion lymphomaprotein degradationprotein misfoldingresearch studytumortumorigenesistumorigenicubiquitin-protein ligasevirus host interaction
中文摘要
摘要/摘要
标题:vGPCR发病机制的翻译后事件
与卡波西肉瘤(KS)相关的人类伽玛疱疹病毒
疱疹病毒(KSHV)通常与免疫缺陷病毒-1和
在患者中诱发肿瘤。除潜伏蛋白外,KSHV裂解蛋白已被
被证明具有致瘤或促进生长的活性,表明溶血
复制可能有助于KS和其他KSHV相关疾病的进展
恶性肿瘤。一个有趣的例子是KSHV编码的G蛋白偶联受体
(VGPCR)。尽管vGPCR下游的致瘤性和信号事件
更好的定义是,尚不清楚vGPCR是如何受到监管的。事实上,不断表达的
成分活性GPCRs(如vGPCR或视网膜视紫红质)诱导的细胞死亡
哺乳动物细胞,增加了KSHV进化控制机制的可能性
VGPCR的表达和活性。
我们的初步研究发现,K7膜蛋白与
VGPCR并诱导其蛋白酶体降解。此外,K7将vGPCR保留在
ER和增加vGPCR泛素化。我们假设K7诱导ER-
VGPCR的联合降解及其负性调节作用
肿瘤发生学。我们的研究建议阐明K7在路由中的分子作用
VGPCR对内质网相关的降解。我们将同时使用遗传和生化技术
鉴定细胞因子及其在K7诱导的vGPCR中的作用的方法
退化。这些实验不仅将阐明细胞内的调节
VGPCR,但也将揭示潜在的抗靶向细胞分子
病毒疗法。
英文摘要
Abstract/Summary
Title: Post-translational events underlying the pathogenesis of vGPCR
Human gamma herpesviruses such as Kaposi's sarcoma (KS)-associated
herpesvirus (KSHV) are often associated with infection of immunodeficiency virus-1 and
induce tumor in patients. In addition to latent proteins, KSHV lytic proteins have been
demonstrated to possess tumorigenic or growth-promoting activities, indicating that lytic
replication may contribute to the disease progression of KS and other KSHV-associated
malignancies. One intriguing example is the KSHV-encoded G protein-coupled receptor
(vGPCR). Although tumorigenicity and signaling events downstream of vGPCR are
better defined, it is not clear how vGPCR is regulated. In fact, continuous expression of
constitutively active GPCRs (e.g., vGPCR or retinal rhodopsin) induced cell death in
mammalian cells, raising the possibility that KSHV has evolved mechanisms to control
vGPCR expression and activity.
Our preliminary study discovered that the K7 membrane protein interacts with
vGPCR and induces its proteasome degradation. Furthermore, K7 retains vGPCR in the
ER and increases vGPCR ubiquitination. We hypothesize that K7 induces the ER-
associated degradation of vGPCR and functions as a negative regulator for vGPCR
tumorigenesis. Our study proposes to elucidate the molecular action of K7 in routing
vGPCR to the ER-associated degradation. We will employ both genetic and biochemical
assays to identify cellular factors and characterize their roles in K7-induced vGPCR
degradation. These experiments not only will elucidate the intracellular regulation of
vGPCR, but also will reveal cellular molecules that can be potentially targeted for anti-
viral therapy.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Dissecting host-virus interaction in lytic replication of a model herpesvirus.
剖析模型疱疹病毒裂解复制中宿主与病毒的相互作用。
DOI:
10.3791/3140
发表时间:
2011
期刊:
Journal of visualized experiments : JoVE
影响因子:
--
作者:
[Dong,Xiaonan, Feng,Pinghui]
通讯作者:
Feng,Pinghui
Recent advances on viral manipulation of NF-κB signaling pathway.
NF-κB信号通路病毒操纵的最新进展。
DOI:
10.1016/j.coviro.2015.08.013
发表时间:
2015-12
期刊:
Current opinion in virology
影响因子:
5.9
作者:
[Zhao J, He S, Minassian A, Li J, Feng P]
通讯作者:
Feng P
DOI:
10.1016/j.bcp.2016.03.021
发表时间:
2016-08-15
期刊:
Biochemical pharmacology
影响因子:
5.8
作者:
[Zhang J, Feng H, Xu S, Feng P]
通讯作者:
Feng P
DOI:
10.1016/j.coviro.2013.05.011
发表时间:
2013-06
期刊:
CURRENT OPINION IN VIROLOGY
影响因子:
5.9
作者:
[Feng, Pinghui, Moses, Ashlee, Frueh, Klaus]
通讯作者:
Frueh, Klaus
DOI:
10.3791/51078
发表时间:
2014-03
期刊:
Journal of visualized experiments : JoVE
影响因子:
--
作者:
[Junjie Zhang;Lining Zhu;P. Feng]
通讯作者:
Junjie Zhang;Lining Zhu;P. Feng
共 8 条
Targeting IKKepsilon-mediated nucleotide synthesis in KSHV-associated lymphoma
-
批准号:10762816
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2023
-
负责人:Pinghui Feng
-
依托单位:
Explore roles of HSV-1 in Alzheimer's disease using mouse models
-
批准号:10629403
-
项目类别:
-
资助金额:$79.9万
-
财政年份:2021
-
负责人:Pinghui Feng
-
依托单位:
Exploring roles of protein deamidation in oral inflammation
-
批准号:9752511
-
项目类别:
-
资助金额:$104.23万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
Exploring roles of protein deamidation in oral inflammation
-
批准号:9461929
-
项目类别:
-
资助金额:$67.72万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
NFAT activation in kGPCR tumorigenesis
-
批准号:9410699
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
NFAT activation in kGPCR tumorigenesis
-
批准号:10251852
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
Targeting an immune kinase to purge KSHV latent infection
-
批准号:9116597
-
项目类别:
-
资助金额:$67.66万
-
财政年份:2016
-
负责人:Pinghui Feng
-
依托单位:
Targeting an immune kinase to purge KSHV latent infection
-
批准号:9242614
-
项目类别:
-
资助金额:$67.66万
-
财政年份:2016
-
负责人:Pinghui Feng
-
依托单位:
A recombinant virus approach for gamma herpesvirus oncogenesis
-
批准号:8638543
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2013
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8184241
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Protein Deamidation in Innate Immune Evasion Regulated by Viral Pseudo Enzymes
-
批准号:9381580
-
项目类别:
-
资助金额:$45.48万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8846572
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8469753
-
项目类别:
-
资助金额:$39.36万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8326568
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8246529
-
项目类别:
-
资助金额:$32.98万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8060647
-
项目类别:
-
资助金额:$10.04万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:7755457
-
项目类别:
-
资助金额:$31.39万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8367335
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
INHIBITION OF MITOCHONDRION-DEPENDENT APOPTOSIS BY HERPESVIRAL PROTEIN
-
批准号:7715509
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2008
-
负责人:Pinghui Feng
-
依托单位:
GAMMAHV68 VMAP MITOCHONDRIAL ANTI-APOPTOSIS PROTEIN
-
批准号:7562107
-
项目类别:
-
资助金额:$3.16万
-
财政年份:2007
-
负责人:Pinghui Feng
-
依托单位:
海外基金